Residual β-cell function after 10 years of autoimmune type 1 diabetes: prevalence, possible determinants, and implications for metabolism

Abstract

Background: Type 1 diabetes (T1D) has long been considered a progressive autoimmune disease resulting in the failure of pancreatic beta-cell function and absolute endogenous insulin deficiency. However, several studies have demonstrated patients with T1D have detectable C-peptide levels long after diagnosis, which has remarkable clinical significance. Since this issue has not been systematically explored in non-Caucasian populations, we aimed to identify the prevalence of residual beta-cell function and its related clinical features in Chinese long-term T1D patients. Methods: We enrolled 109 patients with T1D for >= 10 years and administered a mixed-meal tolerance test (MMTT). Fasting and postprandial C-peptide (FCP/PCP) levels were measured to evaluate the insulin secretion function of beta-cells. Patients whose FCP and PCP levels were both below the lower detection limit (16.7 pmol/L) were grouped as `beta-cell function depleted', while others were thought to have `residual beta-cell function'. Demographic data, metabolic status, and diabetic complications were compared between patients with or without residual beta-cell function. Results: 38.5% of subjects retained residual beta-cell function, and among those, 33.3% responded to MMTT by a two-fold or greater rise of their FCP levels. Clinical features associated with residual beta-cell function were older age of diagnosis {[}27.5 (interquartile range:11.5-37.0) vs. 17.0 (interquartile range: 8.0-30.0) years, P=0.037], lower HbA1c (64.6 +/- 20.3 vs. 72.4 +/- 18.5 mmol/ mol, P=0.026), and reduced rate of hypoglycemia (23.8% vs. 52.2%, P=0.003). Age of diagnosis was positively correlated with detectable FCP level (r=0.393, P=0.020). Individuals diagnosed after 30 years of age tended to retain residual beta-cell function (OR =3.016, P=0.044). We found no association between residual beta-cell function and chronic diabetic complications. Conclusions: Residual beta-cell function can be found in nearly 40% of long-term patients with T1D in China and is associated with older age at diagnosis and better glucose control. The relationship between residual beta-cell function and chronic diabetic complications remains to be explored.